Copyright
©The Author(s) 2022.
World J Gastroenterol. Apr 14, 2022; 28(14): 1394-1404
Published online Apr 14, 2022. doi: 10.3748/wjg.v28.i14.1394
Published online Apr 14, 2022. doi: 10.3748/wjg.v28.i14.1394
Ref. | # Patients | # Patients with functional assessment | Follow-up time | Instrument to evaluate ano-rectal function | Results |
Borstlap et al[17], 2018 | 30 | 15 | 6, 9, 12 mo | LARS score; COREFO | 81% major LARS; 13% minor LARS |
Huisman et al[36], 2019 | 20 | 13 | 2.6 (0.8-3.5) yr | LARS score | 77% major LARS; 23% minor LARS |
Katz et al[42], 2018 | 6 | 4 | Not reported | None | Reasonable function |
Srinivasamurthy et al[14], 2013 | 8 | 6 | 41 (10-45) mo | None | Good or reasonable function |
Abdalla et al[24], 2020 | 47 | 17 | 14.8 ± 8.9 mo | LARS score | 47.1% major LARS; 52.9% no or minor LARS |
Rottoli et al[12], 2018 | 8 (pouch) | 7 | 11.6 (6-18) mo | None | No feces or gas incontinence; BM: Daytime: 5 (3-8); Nighttime: 1.7 (1-4) |
Weréen et al[43], 2020 | 14 | 6 | 5.9 (0.53-13) yr | LARS score | 67% major LARS |
- Citation: Vignali A, De Nardi P. Endoluminal vacuum-assisted therapy to treat rectal anastomotic leakage: A critical analysis. World J Gastroenterol 2022; 28(14): 1394-1404
- URL: https://www.wjgnet.com/1007-9327/full/v28/i14/1394.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i14.1394